BAVARIAN NORDIC DELIVER 1 MILLION SPALLPOX

KVISTGÅRD, Denmark -July 13, 2010 - Bavarian Nordic A/S (NASDAQ OMX: BAVA) announced today that it has delivered 1 million doses of its smallpox vaccine IMVAMUNE® to the U.S. Strategic National Stockpile for use in the event of a smallpox bioterrorism attack on the U.S.

IMVAMUNE® is the first vaccine successfully developed under Project BioShield, a U.S. program created by Congress in 2004 to develop and purchase medicines and vaccines to protect the American public from bioterrorism attacks. Bioterrorism experts are concerned about the possibility of an attack on the US that exposes the population to the smallpox virus.

IMVAMUNE® was clinically developed and manufactured under contracts with the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health & Human Services (HHS), as well as the National Institutes of Health (NIH). Under the BARDA contract, Bavarian Nordic will deliver 20 million doses of IMVAMUNE® to the U.S. Strategic National Stockpile, with an option for 60 million more doses.

.....

Security experts-including the U.S. Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism-expect that an act of biological terrorism is more likely than nuclear terrorism. Compared to a nuclear weapon, a biological weapon is much cheaper to produce, the starting materials are more accessible, and less diversity of technological experience is required. HHS considers smallpox a high-priority threat.

Because vaccination against smallpox is no longer standard, an increasing proportion of the population is unprotected and vulnerable to a bioterrorism attack. Smallpox presents a continued global threat for which countries need to be prepared.

The U.S. Strategic National Stockpile includes stocks of conventional smallpox vaccines made from a live, replicating form of the vaccinia virus. These vaccines were used in a global effort to wipe out the disease and resulted in worldwide eradication by 1980.

EDITOR NOTE: Smallpox vaccine has been linked with the introduction of AIDS

Since H1N1 didn't work too well for the NWO can we now expect a False Flag Bio attack using military grade smallpox?

ENTIRE ARTICLE HERE

EDITORS NOTE: GET YOUR SAVINGS IN GOLD AS SOON AS POSSIBLE! THE DOLLAR IS GOING TO COLLAPSE AND YOUR MONEY WILL BE USELESS! DON'T WAIT! WE RECOMMEND SWISS AMERICA (LINK BELOW) AS WE HAVE BOUGHT GOLD FROM THEM IN THE PAST. THEY ARE RELIABLE AND TRUST WORTHY!


				*BAVARIAN NORDIC DELIVER 1 MILLION DOSES OF SMALLPOX VACCINE IN PREPARATION FOR BIO ATTACK*



	Home \| About Us \| Contact and Links \| Get Educated \| Upcoming Events \| Link to Us \| Downloads \| Archives


		BAVARIAN NORDIC DELIVERS 1 MILLION DOSES OF SMALLPOX VACCINE TO U.S. STRATEGIC NATIONAL STOCKPILE



		Share KVISTGÅRD, Denmark -July 13, 2010 - Bavarian Nordic A/S (NASDAQ OMX: BAVA) announced today that it has delivered 1 million doses of its smallpox vaccine IMVAMUNE® to the U.S. Strategic National Stockpile for use in the event of a smallpox bioterrorism attack on the U.S. IMVAMUNE® is the first vaccine successfully developed under Project BioShield, a U.S. program created by Congress in 2004 to develop and purchase medicines and vaccines to protect the American public from bioterrorism attacks. Bioterrorism experts are concerned about the possibility of an attack on the US that exposes the population to the smallpox virus. IMVAMUNE® was clinically developed and manufactured under contracts with the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health & Human Services (HHS), as well as the National Institutes of Health (NIH). Under the BARDA contract, Bavarian Nordic will deliver 20 million doses of IMVAMUNE® to the U.S. Strategic National Stockpile, with an option for 60 million more doses. ..... Security experts-including the U.S. Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism-expect that an act of biological terrorism is more likely than nuclear terrorism. Compared to a nuclear weapon, a biological weapon is much cheaper to produce, the starting materials are more accessible, and less diversity of technological experience is required. HHS considers smallpox a high-priority threat. Because vaccination against smallpox is no longer standard, an increasing proportion of the population is unprotected and vulnerable to a bioterrorism attack. Smallpox presents a continued global threat for which countries need to be prepared. The U.S. Strategic National Stockpile includes stocks of conventional smallpox vaccines made from a live, replicating form of the vaccinia virus. These vaccines were used in a global effort to wipe out the disease and resulted in worldwide eradication by 1980. EDITOR NOTE: Smallpox vaccine has been linked with the introduction of AIDS Since H1N1 didn't work too well for the NWO can we now expect a False Flag Bio attack using military grade smallpox? ENTIRE ARTICLE HERE EDITORS NOTE: GET YOUR SAVINGS IN GOLD AS SOON AS POSSIBLE! THE DOLLAR IS GOING TO COLLAPSE AND YOUR MONEY WILL BE USELESS! DON'T WAIT! WE RECOMMEND SWISS AMERICA (LINK BELOW) AS WE HAVE BOUGHT GOLD FROM THEM IN THE PAST. THEY ARE RELIABLE AND TRUST WORTHY!



		Powered by Register.com